Vanta Bioscience Ltd - 540729 - Closure of Trading Window
The trading window for transactions in shares of the Company for all designated persons and their immediate relatives will be closed from October 01, 2021 till the 48 hours after the declaration of un-audited financial results of the Company for the half year ended September 30, 2021 Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company
Update in the matter of NCLT application under section 9 of Insolvency and Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 filed against the Company Vanta Bioscience Ltd - 540729 - Receipt Of Approval From Registrar Of Companies Granting Extension Of Time For Holding The 5Th AGM
Receipt of approval from Registrar of Companies granting extension of time for holding the 5th AGM Vanta Bioscience Ltd - 540729 - Receipt Of Full Accreditation Status From AAALAC International, USA
Receipt of full accreditation status from AAALAC International, USA Vanta Bioscience Ltd - 540729 - Extension Of Time To Hold The 5Th AGM Of The Company
Extension of time to hold the 5th AGM of the Company Vanta Bioscience Ltd - 540729 - Intimation Regarding GLP Re-Certification In Vanta Bioscience Limited And Commencement Of Commercial Operations In Vayam Research Solutions Limited
Intimation regarding GLP re-certification in Vanta Bioscience Limited and commencement of commercial operations in Vayam Research Solutions Limited Vanta Bioscience Ltd - 540729 - Intimation Regarding NABL'S Recommendation To Continue The Biological Testing Accreditation Granted To The Company
We are glad to inform you that NABL has completed its surveillance audit and has recommended continuation of Company's existing accreditation in accordance with ISO/IEC 17025:2017 in the discipline of Biological Testing without any observations or remarks. Vanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb SayaniDesignation :- Company Secretary and Compliance Officer Vanta Bioscience Ltd - 540729 - Audited Financial Result For Half Year And Year Ended 31.03.2021
Audited Financial Result for Half Year and Year ended 31.03.2021 Vanta Bioscience Ltd - 540729 - Audited Financial Result For Half Year And Year Ended 31.03.2021
Audited Financial Result for Half Year and Year ended 31.03.2021